NCT00599079已完成4 期
Open, Noncomparative Trial of Azithromycin in the Treatment of M.Avium Complex (MAC) Lung Disease
适应症
干预措施
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 66
- 试验地点
- 1
- 主要终点
- Clinical and microbiological outcomes such as clinical symptoms and laboratory cultures
研究概览
简要总结
To determine the safety and efficacy of azithromycin in the treatment of lung infection with M.avium complex and M. abscessus lung disease.
详细描述
To study the safety and efficacy of azithromycin in combination treatment for M. abscessus and MAC lung disease
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Meet American Thoracic Society criteria for nontuberculous lung disease: two or more AFB smear positive, culture positive sputums or bronchoscopic samples and/or two or more AFB smear negative respiratory samples with moderate to heavy growth (2+-4+); abnormal CXR consistent with M. avium lung disease; abnormal CXR consistent with M. avium lung disease; absence of other lung pathogens (except for the coexistence of M. abscessus).
- •Age 18 and older
- •Pretreatment isolate of M. avium complex available for MIC determination
排除标准
- •History of macrolide allergy
- •Received macrolide therapy in last two months
- •Children less than 18 years of age
- •If a menstruating female, not pregnant and on adequate birth control
研究组 & 干预措施
Azithromycin
Experimental
Azithromycin combined with 2 other drugs given 3 times weekly for MAc lung disease
干预措施: Azithromycin (Drug)
结局指标
主要结局
Clinical and microbiological outcomes such as clinical symptoms and laboratory cultures
时间窗: 6 months
neg cultures X3( sputum conversion)
次要结局
- Microbiological cultures(1yr)
研究者
Richard J. Wallace, Jr., M.D.
Chairman Department of Microbiology
The University of Texas Health Science Center at Tyler
研究点 (1)
Loading locations...
相似试验
已完成
不适用
An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current TherapyMycobacterium Avium-Intracellulare InfectionHIV InfectionsNCT00002089Pfizer
Unknown
4 期
Azithromycin in Hospitalized COVID-19 PatientsCOVID-19NCT04359316Shahid Beheshti University of Medical Sciences40
已完成
2 期
Trial II of Lung Protection With Azithromycin in the Preterm InfantBronchopulmonary DysplasiaNCT00319956Hubert Ballard220
已完成
4 期
Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's DiseaseCrohn's DiseaseNCT01596894Prof. Arie Levine73
已完成
3 期
Azithromycin/Bicillin SyphilisSyphilisNCT00031499National Institute of Allergy and Infectious Diseases (NIAID)593